Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the impact of the restriction of puberty blockers for the treatment of gender incongruence on the (a) physical and (b) mental health of young trans people.

On 11 December 2024 the Government introduced The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024, which came into effect on 1 January 2025. Alongside this legislation the Government published a full impact assessment, which is available at the following link:

https://www.legislation.gov.uk/uksi/2024/1319/impacts